ELEVATION OF C-REACTIVE PROTEIN IN ACTIVE CORONARY-ARTERY DISEASE

被引:470
|
作者
BERK, BC [1 ]
WEINTRAUB, WS [1 ]
ALEXANDER, RW [1 ]
机构
[1] HARVARD UNIV, BRIGHAM & WOMENS HOSP,SCH MED,DEPT MED, DIV CARDIOVASC, BOSTON, MA 02115 USA
来源
AMERICAN JOURNAL OF CARDIOLOGY | 1990年 / 65卷 / 03期
关键词
D O I
10.1016/0002-9149(90)90079-G
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Unstable angina occurs most commonly in the setting of atherosclerotic coronary artery disease (CAD), but there is little information concerning the mechanisms responsible for the transition from clinically stable to unstable coronary atherosclerotic plaque. Recently, increased focal infiltration of inflammatory cells into the adventitia of coronary arteries of patients dying suddenly from CAD and activation of circulating neutrophils in patients with unstable angina have been observed. To characterize the presence of inflammation in "active" atherosclerotic lesions, the acute phase reactant C-reactive protein (CRP) was measured in 37 patients admitted to the coronary care unit with unstable angina, 30 patients admitted to the coronary care unit with nonischemic illnesses and 32 patients with stable CAD. CRP levels were significantly elevated (normal < 0.6 mg/dl) in 90% of the unstable angina group compared to 20% of the coronary care unit group and 13% of the stable angina group. The average CRP values were significantly different (p = 0.001) for the unstable angina group (2.2 ± 2.9 mg/dl) compared to the coronary care (0.9 ± 0.7 mg/dl) and stable angina (0.7 ± 0.2 mg/ dl) groups. There was a trend for unstable angina patients wtth ischemic ST-T-wave abnormalities to have higher CRP values (2.6 ± 3.4) than those without etectrocardiographic changes (1.3 ± 0.9, p = 0.1). The data demonstrate increased levels of an acute phase reactant in unstable angina. These findings suggest that an inflammatory component in "active" angina may contribute to the susceptibility of these patients to vasospasm and thrombosis. © 1990.
引用
收藏
页码:168 / 172
页数:5
相关论文
共 50 条
  • [41] Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease
    Nissen, SE
    Tuzcu, EM
    Schoenhagen, P
    Crowe, T
    Sasiela, WJ
    Tsai, J
    Orazem, J
    Magorien, RD
    O'Shaughnessy, C
    Ganz, P
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (01): : 29 - 38
  • [42] Elevated C-reactive protein levels and coronary microvascular dysfunction in patients with coronary artery disease
    Tomai, F
    Ribichini, F
    Ghini, AS
    Ferrero, V
    Andò, G
    Vassanelli, C
    Romeo, F
    Crea, F
    Chiariello, L
    EUROPEAN HEART JOURNAL, 2005, 26 (20) : 2099 - 2105
  • [43] Risk Stratification for Primary Prevention of Coronary Artery Disease: Roles of C-Reactive Protein and Coronary Artery Calcium
    Qureshi, Waqas T.
    Rana, Jamal S.
    Yeboah, Joseph
    bin Nasir, Usama
    Al-Mallah, Mouaz H.
    CURRENT CARDIOLOGY REPORTS, 2015, 17 (12)
  • [44] Predictive value of coronary artery stenoses and C-reactive protein levels in patients with stable coronary artery disease
    Arroyo-Espliguero, Ramon
    Avanzas, Pablo
    Quiles, Juan
    Kaski, Juan Carlos
    ATHEROSCLEROSIS, 2009, 204 (01) : 239 - 243
  • [45] Risk Stratification for Primary Prevention of Coronary Artery Disease: Roles of C-Reactive Protein and Coronary Artery Calcium
    Waqas T. Qureshi
    Jamal S. Rana
    Joseph Yeboah
    Usama bin Nasir
    Mouaz H. Al-Mallah
    Current Cardiology Reports, 2015, 17
  • [46] Predictive value of coronary artery stenoses and C-reactive protein levels in patients with stable coronary artery disease
    Avanzas, P.
    Arroyo-Espliguero, R.
    Quiles, J.
    Kaski, J. C.
    CIRCULATION, 2008, 118 (12) : E166 - E166
  • [47] Pretreatment with statins, C-reactive protein and multifocal activation of coronary artery disease in patients with non-ST-elevation acute coronary syndromes
    Zairis, M
    Lyras, A
    Bibis, G
    Psaltiras, G
    Papadaki, O
    Anastassiadis, F
    Beldekos, D
    Foussas, SG
    EUROPEAN HEART JOURNAL, 2003, 24 : 346 - 346
  • [48] Eptifibatide reduces C-reactive protein elevation after coronary angioplasty
    Merino, A
    Artaiz, M
    Bergada, J
    Vidal, B
    Riera, M
    Zarzar, J
    Albertos, J
    Rodriguez, A
    EUROPEAN HEART JOURNAL, 2001, 22 : 720 - 720
  • [49] The effect of simvastatin on C-reactive protein in dyslipidemic hypertensives with or without coronary artery disease
    Karagkiozaki, V
    Borghi, L
    Koukoutsis, I
    Passalidou, M
    Litsas, I
    Terzi, S
    Gotsis, A
    Tsaraktsidou, T
    Koutsogiannis, O
    JOURNAL OF HYPERTENSION, 2004, 22 : S390 - S390
  • [50] Association of C-reactive protein and fibrinogen with the severity of angiographically verified coronary artery disease
    Spasojevic-Kalimanovska, V.
    Memon, L.
    Bogavac-Stanojevic, N.
    Ostric-Kalimanovska, D.
    Jelic-Ivanovic, Z.
    Spasic, S.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 279 - 279